NRx Pharmaceuticals Takes Bold Steps Against Short Sellers, Plans to Rebrand as NRx Therapeutics
RADNOR, PA — In a decisive move on March 12, 2024, NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) unveiled a comprehensive strategy aimed at curtailing short-selling activities that have beleaguered the company’s …
NRx Pharmaceuticals Takes Bold Steps Against Short Sellers, Plans to Rebrand as NRx Therapeutics Read More